Search research articles
Contact Us
Filters
Showing results (221-230 of 280) with videos related to
Page
of 28
Sort By:
Blood
|
August 29, 2000
Prognostic significance of survivin expression in diffuse large B-cell lymphomas
C Adida, C Haioun, P Gaulard, et al.
Ebiomedicine
|
September 23, 2019
Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer
Jae Ho Seo, Ekta Agarwal, Young Chan Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2010
Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer
Byoung Heon Kang, Markus D Siegelin, Janet Plescia, et al.
Cancer Biology & Therapy
|
February 21, 2022
Small extracellular vesicle-mediated <i>ITGB6</i> siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells
Shiv Ram Krishn, Vaughn Garcia, Nicole M Naranjo, et al.
Scientific Reports
|
August 27, 2024
Role of Kindlin 2 in prostate cancer
Katarzyna Bialkowska, Lamyae El Khalki, Priyanka S Rana, et al.
Cancer Cell
|
May 17, 2005
Rational design of shepherdin, a novel anticancer agent
Janet Plescia, Whitney Salz, Fang Xia, et al.
Oncotarget
|
January 20, 2018
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
Kelly G Bryant, Young Chan Chae, Rogelio L Martinez, et al.
Journal of Cellular Physiology
|
June 4, 2014
microRNA-mediated survivin control of pluripotency
Kristina Kapinas, Heesun Kim, Matthew Mandeville, et al.
British Journal of Cancer
|
February 3, 2011
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
B H Kang, M Tavecchio, H L Goel, et al.
Diabetes
|
July 5, 2008
Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin
Yuying Jiang, Wataru Nishimura, Deborah Devor-Henneman, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 280) with videos related to
Sort By:
Page
of 28
Blood
|
August 29, 2000
Prognostic significance of survivin expression in diffuse large B-cell lymphomas
C Adida, C Haioun, P Gaulard, et al.
Ebiomedicine
|
September 23, 2019
Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer
Jae Ho Seo, Ekta Agarwal, Young Chan Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2010
Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer
Byoung Heon Kang, Markus D Siegelin, Janet Plescia, et al.
Cancer Biology & Therapy
|
February 21, 2022
Small extracellular vesicle-mediated <i>ITGB6</i> siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells
Shiv Ram Krishn, Vaughn Garcia, Nicole M Naranjo, et al.
Scientific Reports
|
August 27, 2024
Role of Kindlin 2 in prostate cancer
Katarzyna Bialkowska, Lamyae El Khalki, Priyanka S Rana, et al.
Cancer Cell
|
May 17, 2005
Rational design of shepherdin, a novel anticancer agent
Janet Plescia, Whitney Salz, Fang Xia, et al.
Oncotarget
|
January 20, 2018
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
Kelly G Bryant, Young Chan Chae, Rogelio L Martinez, et al.
Journal of Cellular Physiology
|
June 4, 2014
microRNA-mediated survivin control of pluripotency
Kristina Kapinas, Heesun Kim, Matthew Mandeville, et al.
British Journal of Cancer
|
February 3, 2011
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
B H Kang, M Tavecchio, H L Goel, et al.
Diabetes
|
July 5, 2008
Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin
Yuying Jiang, Wataru Nishimura, Deborah Devor-Henneman, et al.
Page
of 28